Literature DB >> 17693442

Vascular pathology and osteoarthritis.

D M Findlay1.   

Abstract

There is mounting evidence that vascular pathology plays a role in the initiation and/or progression of the major disease of joints: osteoarthritis (OA). Potential mechanisms are: episodically reduced blood flow through the small vessels in the subchondral bone at the ends of long bones, and related to this, reduced interstitial fluid flow in subchondral bone. Blood flow may be reduced by venous occlusion and stasis or by the development of microemboli in the subchondral vessels. There are several likely effects of subchondral ischaemia: the first of these is compromised nutrient and gas exchange into the articular cartilage, a potential initiator of degradative changes in the cartilage. The second is apoptosis of osteocytes in regions of the subchondral bone, which would initiate osteoclastic resorption of that bone and at least temporarily reduce the bony support for the overlying cartilage. It may be important to recognize these potential aetiological factors in order to develop more effective treatments to inhibit the progression of OA.

Entities:  

Mesh:

Year:  2007        PMID: 17693442     DOI: 10.1093/rheumatology/kem191

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  71 in total

Review 1.  Osteocyte regulation of bone mineral: a little give and take.

Authors:  G J Atkins; D M Findlay
Journal:  Osteoporos Int       Date:  2012-08       Impact factor: 4.507

2.  Assessment of lower extremity arterial blood flow in females with knee osteoarthritis.

Authors:  Ahmet Boyaci; Ahmet Tutoglu; Nurefsan Boyaci; Irfan Koca; Rifat Aridici; Erdem Daglioglu; Sema Yildiz
Journal:  Clin Rheumatol       Date:  2013-11-21       Impact factor: 2.980

3.  Metabolic syndrome and components exacerbate osteoarthritis symptoms of pain, depression and reduced knee function.

Authors:  Hongxing Li; Daniel M George; Ruurd L Jaarsma; Xinzhan Mao
Journal:  Ann Transl Med       Date:  2016-04

Review 4.  Management of chronic arthritis pain in the elderly.

Authors:  Mary-Ann Fitzcharles; David Lussier; Yoram Shir
Journal:  Drugs Aging       Date:  2010-06-01       Impact factor: 3.923

5.  Statin Use and Knee Osteoarthritis Outcomes: A Longitudinal Cohort Study.

Authors:  Nicola Veronese; Ai Koyanagi; Brendon Stubbs; Cyrus Cooper; Giuseppe Guglielmi; Renè Rizzoli; Patricia Schofield; Leonardo Punzi; Nasser Al-Daghri; Lee Smith; Stefania Maggi; Jean-Yves Reginster
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-07-08       Impact factor: 4.794

Review 6.  Metabolic syndrome meets osteoarthritis.

Authors:  Qi Zhuo; Wei Yang; Jiying Chen; Yan Wang
Journal:  Nat Rev Rheumatol       Date:  2012-08-21       Impact factor: 20.543

Review 7.  Revealed aspect of metabolic osteoarthritis.

Authors:  Rishmeen Chadha
Journal:  J Orthop       Date:  2016-07-09

8.  Positive association between increased popliteal artery vessel wall thickness and generalized osteoarthritis: is OA also part of the metabolic syndrome?

Authors:  Peter R Kornaat; Ruby Sharma; Rob J van der Geest; Hildo J Lamb; Margreet Kloppenburg; Marie-Pierre Hellio le Graverand; Johan L Bloem; Iain Watt
Journal:  Skeletal Radiol       Date:  2009-07-03       Impact factor: 2.199

9.  Dietary fatty acid intake affects the risk of developing bone marrow lesions in healthy middle-aged adults without clinical knee osteoarthritis: a prospective cohort study.

Authors:  Yuanyuan Wang; Miranda L Davies-Tuck; Anita E Wluka; Andrew Forbes; Dallas R English; Graham G Giles; Richard O'Sullivan; Flavia M Cicuttini
Journal:  Arthritis Res Ther       Date:  2009-05-08       Impact factor: 5.156

10.  Development of bone marrow lesions is associated with adverse effects on knee cartilage while resolution is associated with improvement--a potential target for prevention of knee osteoarthritis: a longitudinal study.

Authors:  Miranda L Davies-Tuck; Anita E Wluka; Andrew Forbes; Yuanyuan Wang; Dallas R English; Graham G Giles; Richard O'Sullivan; Flavia M Cicuttini
Journal:  Arthritis Res Ther       Date:  2010-01-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.